Kovack Advisors Inc. lowered its position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 6.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,129 shares of the semiconductor company’s stock after selling 81 shares during the quarter. Kovack Advisors Inc.’s holdings in Synopsys were worth $548,000 as of its most recent SEC filing.
Several other hedge funds have also made changes to their positions in the company. Hazlett Burt & Watson Inc. lifted its holdings in shares of Synopsys by 40.0% in the third quarter. Hazlett Burt & Watson Inc. now owns 70 shares of the semiconductor company’s stock valued at $35,000 after purchasing an additional 20 shares in the last quarter. Caprock Group LLC lifted its stake in Synopsys by 0.5% in the 4th quarter. Caprock Group LLC now owns 3,714 shares of the semiconductor company’s stock worth $1,803,000 after acquiring an additional 20 shares in the last quarter. Compagnie Lombard Odier SCmA boosted its position in Synopsys by 1.1% during the 4th quarter. Compagnie Lombard Odier SCmA now owns 1,850 shares of the semiconductor company’s stock worth $898,000 after acquiring an additional 20 shares during the period. Edge Capital Group LLC boosted its position in Synopsys by 1.2% during the 4th quarter. Edge Capital Group LLC now owns 1,629 shares of the semiconductor company’s stock worth $791,000 after acquiring an additional 20 shares during the period. Finally, Aptus Capital Advisors LLC grew its stake in Synopsys by 1.5% during the 3rd quarter. Aptus Capital Advisors LLC now owns 1,447 shares of the semiconductor company’s stock valued at $733,000 after acquiring an additional 22 shares in the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Synopsys Price Performance
Shares of NASDAQ:SNPS opened at $457.28 on Friday. The stock has a market capitalization of $70.69 billion, a P/E ratio of 31.49, a P/E/G ratio of 3.23 and a beta of 1.12. The business has a 50-day moving average of $506.14 and a two-hundred day moving average of $515.69. Synopsys, Inc. has a fifty-two week low of $448.11 and a fifty-two week high of $624.80.
Wall Street Analyst Weigh In
Read Our Latest Report on SNPS
Insider Buying and Selling
In other Synopsys news, CRO Richard S. Mahoney sold 20,838 shares of the stock in a transaction that occurred on Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total transaction of $10,544,236.38. Following the transaction, the executive now owns 1,460 shares in the company, valued at $738,774.60. This trade represents a 93.45 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 0.62% of the company’s stock.
Synopsys Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Read More
- Five stocks we like better than Synopsys
- Short Selling: How to Short a Stock
- Analysts Lift Archer Aviation Stock Despite Earnings Miss
- What is a penny stock? A comprehensive guide
- 5 Best Gold ETFs for March to Curb Recession Fears
- When to Sell a Stock for Profit or Loss
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.